About this trial
The project is a collaboration between The National Centre for Suicide Research and Prevention (NSSF) and clinical units with Dialectical Behaviour Therapy (DBT) programmes. A methodological and technological platform has been established that enables clinicians to deliver high quality treatments over extended periods of time, to evaluate their own performance and productivity and to report it in a uniform and systematic way that will enable comparison across clinical settings and programmes. The collected data constitute the basis for conducting the clinical study with the overall aim to study predictors of the clinical course and treatment response in patients admitted to DBT programmes in Norway.
Eligibility criteria
Qualifiers
History of repeated deliberate self harm
Satisfies criteria of Diagnostic and Statistical Manual (DSM-IV) Borderline Personality Disorder as measured by Structured Clinical Interview for the DSM (SCID-II) in addition to the self-destructive criterion.
Disqualifiers
Psychotic disorders
Anorexia Nervosa
Substance dependence disorder
Mental retardation (IQ less than 70)
Trial design
Treatments tested in this trial
- Dialectical Behaviour Therapy adapted for adolescents (DBT-A)
- Dialectical Behaviour Therapy - Standard version (DBT)
Treatment groups
Sponsors and collaborators
Oslo University Hospital
Lead sponsor
Vestre Viken Hospital Trust
Collaborator
St. Olavs Hospital
Collaborator
Sykehuset Ostfold
Collaborator
University of Oslo
Collaborator
Nordlandssykehuset HF
Collaborator